Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Insulin,Inapplicable
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
December 18, 2015
Lead Product(s) : Insulin,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Insulin Lispro,Inapplicable
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH | Parexel
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
December 18, 2015
Lead Product(s) : Insulin Lispro,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH | Parexel
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Human Biphasic Insulin,Inapplicable
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
December 16, 2015
Lead Product(s) : Human Biphasic Insulin,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Profil Institut für Stoffwechselforschung GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable